NCT07780656 clinical trial report covering SHR-1905, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07778836 clinical trial report covering Nomlabofusp, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07780669 clinical trial report covering SHR-1905, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07780643 clinical trial report covering SHR-1905, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07778693 clinical trial report covering MWN-109, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07779538 clinical trial report covering Trastuzumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07778667 clinical trial report covering Lucerastat, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07779252 clinical trial report covering Botulinum toxin A(Medytox), Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07779746 clinical trial report covering Apixaban, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07783425 clinical trial report covering Tilrekimig, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07782996 clinical trial report covering SHR-1905, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07782970 clinical trial report covering SHR-1905, Phase 3, endpoints, sponsor, geography, readout timing and development white space.